Browse by category

Adults with obesity and diabetes face higher health care utilisation costs with GLP-1s treatment compared with Bariatric metabolic surgery (BMS), excluding intervention costs, largely reflecting differences in early clinical trajectories, according to a study by researchers from Israel. These findings suggest that, among patients eligible for both interventions, BMS may confer combined clinical and economic advantages over long-term follow-up. The study was designed to compar